Stryker Corp. (SYK)$316.48

Market Cap: 145.56 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for Stryker Corp. (SYK).

HEALTHCARE

MEDICAL DEVICES

DCF ready

Valuation

33.0x

EV/FCF, 3.0% FCF yield

Quality

14.5%

ROIC, 17.1% FCF margin

Growth

11.8%

5Y sales (revenue) CAGR

Balance sheet

0.0x

Debt/equity, 1.9x current ratio

Superinvestors

Top: Terry Smith (7.8%)

Strengths to research

Revenue compounded at 11.8% over five years.
Free cash flow compounded at 9.0% over five years.
Free cash flow margin is healthy at 17.1%.
Debt/equity looks manageable at 0.0x.

Watchouts

No major valuation, balance sheet, or growth watchouts were detected by the static screen.

Annual data: 10 periods

Quarterly data: 24 periods

Stock snapshot: May 25, 2026

Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for SYK.

Grade B

/ 100

Compare to:

LLY JNJ UNH ABBV NVO

Peer Comparison

Target stock against 6 market-cap comparable peers.

Heat map: red worst to green best


SYK Target	Stryker Corp.	$145.6B	37.7x	33.0x	14.5%	11.8%	17.1%	64.0%	-0.6x	N/A
BSX	Boston Scientific	$154.2B	29.8x	41.6x	11.9%	15.2%	18.2%	69.0%	-0.4x	N/A
MDT	Medtronic plc	$107.0B	21.8x	20.2x	9.7%	3.0%	15.5%	N/A	-0.3x	N/A
ABT	Abbott Labs	$230.7B	23.5x	31.8x	10.0%	5.1%	16.7%	N/A	0.5x	N/A
EW	Edwards Lifesciences Corp.	$44.0B	46.9x	30.8x	10.4%	6.7%	22.0%	78.0%	-2.1x	N/A
DXCM	DEXCOM, INC.	$31.5B	34.5x	28.4x	30.5%	19.3%	23.1%	60.1%	-0.8x	N/A
STE	STERIS plc	$22.0B	34.9x	30.6x	7.2%	12.5%	14.3%	44.0%	1.3x	N/A

Financial Charts

No financial data available for SYK (annual).

4 superinvestors own SYK

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership

Fund	Shares	Value	% Portfolio	QoQ Change
Terry Smith Fundsmith	3,061,416	$1.0B	7.84%	0.0%
Jensen Investment Management Jensen Investment Management	696,367	$229M	4.51%	0.0%
Nicolai Tangen AKO Capital	249,883	$82M	1.61%	0.0%
Mairs & Power Growth Fund Mairs & Power Growth Fund	4,155	$1M	0.01%	0.0%